UNH - Pharma CEOs defend high drug prices; blame PBMs at Senate hearing
2024-02-09 07:24:06 ET
More on Bristol-Myers, J&J, etc.
- Bristol-Myers Squibb: All Focus On Execution
- Bristol-Myers Squibb: Massive Discount Spells Opportunity
- Bristol-Myers Squibb Company 2023 Q4 - Results - Earnings Call Presentation
- Bristol Myers granted FDA, EU reviews for Opdivo label expansion
- Johnson & Johnson sued over mismanaging company’s health plan